Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 32161-32170 Newer>

The Motley Fool September 16, 2008 Brian Orelli	Monsanto's Guidance Keeps Growing Monsanto announces another change in financial guidance, which fortunately continued the upward trend.
The Motley Fool September 16, 2008 Barker et al.	The Lesson We Can Learn From Lehman If there's only one thing you take away from the Lehman Brothers, Merrill Lynch, and AIG stories of the past few days, let it be this: If it seems too good to be true, it probably is.
The Motley Fool September 16, 2008 Christopher Barker	Lehman and AIG Weren't the Only Storms This Week Hurricane Ike damaged oil rigs and shut-in significant refinery production.
The Motley Fool September 16, 2008 Anders Bylund	It's On! It's On! It's On! Activision Blizzard and Viacom are staring each other down across the music-game playground.
The Motley Fool September 16, 2008 David Lee Smith	It's Time to Dip Back Into Energy We may have hit the point where energy names are compelling again.
The Motley Fool September 16, 2008 Zoe Van Schyndel	The Final Investment Frontier Does Africa belong in your portfolio?
The Motley Fool September 16, 2008 Rich Smith	This Just In: Upgrades and Downgrades Upgrades and downgrades on grocery sector stocks: Great Atlantic & Pacific Tea... Kroger... Safeway... SUPERVALU... Whole Foods...
The Motley Fool September 16, 2008 Rich Smith	Wal-Mart Opens a Foreign Bank Account Wal-Mart files an application with Canada's Office of the Superintendent of Financial Institutions, seeking permission to open a pocket bank for its Canadian subsidiary.
The Motley Fool September 16, 2008 Toby Shute	How Lehman Socked Your Solar Stock Two recent Lehman Brothers transactions in the solar space, by JA Solar and Evergreen Solar, is now leaving a sour taste in investors' mouths.
The Motley Fool September 16, 2008 Brian Lawler	Pfizer Puts Safety First Increased FDA scrutiny may motivate the pharmaceutical's new drug-safety site.
<Older 32161-32170 Newer> Return to current articles.